RETRACTED ARTICLE: Dclk1, a tumor stem cell marker, regulates pro-survival signaling and self-renewal of intestinal tumor cells
2017 · Molecular Cancer · 122 citations
https://doi.org/10.1186/s12943-017-0594-y
J
Jiannan Yao
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
85
Papers
935
Citations
17
h-index
25
i10-index
Jiannan Yao is an academic researcher from Capital Medical University. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Genetic factors in colorectal cancer & Cancer Genomics and Diagnostics. The author has an h-index of 17, co-authored 73 publications.
ORCID: 0000-0002-4982-4460Papers by this author
worksDCLK1 Suppresses Tumor-Specific Cytotoxic T Lymphocyte Function Through Recruitment of MDSCs via the CXCL1-CXCR2 Axis
2022 · Cellular and Molecular Gastroenterology and Hepatology · 20 citations
https://doi.org/10.1016/j.jcmgh.2022.10.013
Reflection on the teaching of student-centred formative assessment in medical curricula: an investigation from the perspective of medical students
2023 · BMC Medical Education · 15 citations
https://doi.org/10.1186/s12909-023-04110-w
Techniques of TIPS in the treatment of liver cirrhosis combined with incompletely occlusive main portal vein thrombosis
2016 · Scientific Reports · 14 citations
https://doi.org/10.1038/srep33069
GGT5: a potential immunotherapy response inhibitor in gastric cancer by modulating GSH metabolism and sustaining memory CD8+ T cell infiltration
2024 · Cancer Immunology Immunotherapy · 9 citations
https://doi.org/10.1007/s00262-024-03716-3
Corrigendum to “Construction of a novel immune response prediction signature to predict the efficacy of immune checkpoint inhibitors in clear cell renal cell carcinoma patients” Heliyon 9(6), (May 25, 2023)
2023 · Heliyon · 0 citations
https://doi.org/10.1016/j.heliyon.2023.e18515
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat